Daniel Weckbecker

714 citations
15 papers · 546 indexed · 1 hit paper · h-index 11

Impact in

  • Neurology top 5%
    • Parkinson's Disease Mechanisms and Treatments
    • Neurological disorders and treatments
    • Genetic Neurodegenerative Diseases
    • Neuroscience and Neuropharmacology Research

Papers in

    • Parkinson's Disease Mechanisms and Treatments 7
    • Neurological disorders and treatments 5
    • Botulinum Toxin and Related Neurological Disorders 3
    • Genetic Neurodegenerative Diseases 3
    • Neuroscience and Neuropharmacology Research 2

Daniel Weckbecker

15 papers receiving 540 citations

Hit Papers

A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson’s disease 2025 · 13 citations
13202520264812

Peers

Daniel Weckbecker
Comparison fields: 5 of 64
  • Neurology 260
  • Cellular and Molecular Neuroscience 141
  • Physiology 180
  • Clinical Biochemistry 46
  • Neurology 53
Replace Preston Ge with:
Preston Ge United States
Mattia Vicario Italy
Goichi Beck Japan
Inês Caldeira Brás Germany
Srdja Drakulić Denmark
José D. Camino Spain
Shahin Zibaee United Kingdom
Virginie Loeb Israel
Sergey Ryazanov Germany
Houfang Long China
Daniel Weckbecker relative to Preston Ge United States Preston Ge's profile →
Citations per field
00.5×5.7×
Preston Ge · 1×
Citations per year

Countries citing papers authored by Daniel Weckbecker

Since Specialization
Citations

This map shows the geographic impact of Daniel Weckbecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Weckbecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Weckbecker more than expected).

Fields of papers citing papers by Daniel Weckbecker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Weckbecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Weckbecker. The network helps show where Daniel Weckbecker may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Weckbecker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Weckbecker Line = papers co-authored together Daniel Weckbecker links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 201281
2 201879
3 202064
4 201558
5 202257
6 201955
7 201940
8 201236
9 200930
10
A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson’s disease
Hit paper breakdown →
202513
11 201710
12 201910
13 202010
14 20132
15
[C-11]MODAG-001-towards a PET tracer targeting alpha-synuclein aggregates
20211

About Daniel Weckbecker

Daniel Weckbecker is a scholar working on Neurology, Cellular and Molecular Neuroscience, Physiology, Clinical Biochemistry and Neurology, having authored 15 papers that have together received 546 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (7 papers), Neurological disorders and treatments (5 papers), Alzheimer's disease research and treatments (4 papers), Botulinum Toxin and Related Neurological Disorders (3 papers), Genetic Neurodegenerative Diseases (3 papers), Mitochondrial Function and Pathology (3 papers), Neuroscience and Neuropharmacology Research (2 papers) and Metabolism and Genetic Disorders (1 paper). The work is most often cited by research in Neurology (260 citations), Cellular and Molecular Neuroscience (141 citations), Physiology (180 citations), Clinical Biochemistry (46 citations) and Neurology (53 citations). Daniel Weckbecker has collaborated with scholars based in Germany, Denmark and Malta. Frequent co-authors include Johannes M. Herrmann, Andrei Leonov, Sergey Ryazanov, Christian Griesinger, Sebastian Longen, Armin Giese, Jan Riemer, Felix Schmidt, Nadia Stefanova and Gregor K. Wenning. Their work appears in journals such as Acta Neuropathologica, European Journal of Nuclear Medicine and Molecular Imaging, Scientific Reports, The EMBO Journal and Biochimica et Biophysica Acta (BBA) - Biomembranes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026